Why the study?
In the Japanese clinical setting, the prevalence, potential confounders, and prognosis of gastrointestinal bleeding associated with anticoagulant therapy, including DOACs and warfarin, are unclear.
Does DOAC therapy compared to warfarin affect the risk of gastrointestinal bleeding in Japanese patients with atrial fibrillation?
Does DOAC therapy compared to warfarin affect the risk of gastrointestinal bleeding in Japanese patients with atrial fibrillation?
In Japanese patients with atrial fibrillation, DOACs and warfarin have similar rates of gastrointestinal bleeding, which is strongly predicted by baseline anemia and renal impairment and is associated with increased mortality.
Answers are grounded in this paper and cite their sources.
Intensified follow-up may be warranted after GI bleeding on OAC; leaves open whether correcting anemia or renal impairment improves survival.
BACKGROUND: In the Japanese clinical setting, the prevalence, potential cofounders of gastrointestinal (GI) bleeding from anticoagulant therapy, including direct oral anticoagulants (DOACs) and warfarin, and prognosis after GI bleeding are unclear. METHODS AND RESULTS: We examined about GI bleeding from anticoagulant therapy using data from the SAKURA AF Registry, a prospective multicenter registry in Japan. Among 3,237 enrollees, 48.8% (n=1,561) were warfarin users and 51.2% (n=1,676) DOAC users. GI bleeding was identified in 68 patients (2.1%). No incidental differences in GI bleeding were observed between the DOAC and warfarin users (32 [1.9%] patients [0.67 events per 100 person-years] vs. 36 [2.3%] patients [0.75 events per 100 person-years], respectively; P=0.43). Multivariate Cox proportional hazard model analysis revealed that creatinine (hazard ratio [HR] 1.379, 95% confidence interval [CI] 1.091-1.743 P=0.007) and hemoglobin (HR 0.814, 95% CI 0.705-0.941, P=0.005) remained independent determinants of GI bleeding. Patients experiencing GI bleeding events had a higher risk of all-cause death (18%) than those without GI bleeding (6%) (P=0.045). CONCLUSIONS: GI bleeding was strongly associated with anemia and renal impairment. Patients experiencing GI bleeding had higher risk for all-cause death than those without GI bleeding.
No takes yet. Share an insight, caveat, or question.
Murata et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: